国产精品扒开腿做爽爽的视频,无码丰满熟妇juliaann与黑人,无码av天天av天天爽,成在人线无码AⅤ免费视频

服務(wù)熱線

15021010459
技術(shù)文章
當(dāng)前位置:主頁 > 技術(shù)文章 > Ariad抗癌藥Iclusig重返市場

Ariad抗癌藥Iclusig重返市場

更新時間:2014-01-20 點擊次數(shù):1450

    去年Ariad Pharmaceuticals公司業(yè)績由于主打抗癌藥物Iclusig被緊急下架而遭受重創(chuàng)。公司一度陷入困境并將其在美國的員工裁員160人,約占美 國分部總員工數(shù)的40%,以節(jié)省開支。不過現(xiàn)在Ariad Pharmaceuticals公司迎來一絲曙光。公司已經(jīng)著手將Iclusig重新推向市場。此次Ariad將把Iclusig的適用癥范圍縮小,并在 藥物包裝上標(biāo)明可能出現(xiàn)的副作用如心臟病、血液凝塊等。不過由于Iclusig適用范圍變小,公司的收入可能也會大受影響。為解決這一問題公司計劃申請重 啟此前被FDA下令暫停的關(guān)于Iclusig治療慢性白血病的研究計劃以達(dá)到亡羊補(bǔ)牢的作用。

    不過Ariad Pharmaceuticals公司的這一系列舉措能否獲得預(yù)期效果還需要等待公司2014年*季度財報公布后才能知曉。

詳細(xì)英文報道:

    Last year, Ariad Pharmaceuticals ($ARIA) watched more than $2.5 billion melt off its market cap when the cancer-fighting Iclusig began a downward spiral that would eventually remove it from the market. But now begins the rebuilding project, as the Cambridge, MA, drugmaker has relaunched its sole product with a lot of ground to make up.

    The drug is now indicated for a smaller group of leukemia patients than before, and it carries a serious boxed warning about the risk of clotting and heart failure that got it pulled from shelves in the fall. But it is for sale, and that puts Ariad in a better place than many predicted at its nadir.

    "We are back on track," CEO Harvey Berger told Bloomberg last month. "We'll enter 2014 largely where we were as we started off the fall in September."

    Of course, that's not entirely the case. Losing more than half of its value forced Ariad to considerably thin its ranks, laying off 40% of its U.S. workforce--or 160 employees--in an effort to save $26 million. Now the company plans to gradually ramp up stateside sales with the help of specialty pharmacy Biologics, Inc., first looking to transition the case-by-case patients who were still using the drug during its marketing hiatus.

    And the company has a long way to go on the R&D side. When the storm over Iclusig began, Ariad was in the process of testing the drug in a broader population, but an FDA-imposed clinical hold led the company to discontinue a Phase III study on patients with newly diagnosed chronic myeloid leukemia and put the brakes on a fleet of Phase II studies designed to expand the drug's market. Berger has said that Ariad is yet to decide just how to move forward with its paused programs.

    Still, the biotech is undeniably sitting prettier than it was just two months ago, and its next big test will come when Q1 sales figures roll in.——(華雅干細(xì)胞整理報道)

2025 版權(quán)所有 © 重慶市華雅干細(xì)胞技術(shù)有限公司  備案號:渝ICP備14000349號-4 sitemap.xml 管理登陸 技術(shù)支持:化工儀器網(wǎng)

地址:重慶市江北區(qū)金渝大道153號8棟20-14 傳真:023-63419626 郵件:sales@ys-bio.com

重慶市華雅干細(xì)胞技術(shù)有限公司主要經(jīng)營干細(xì)胞研究 干細(xì)胞治療產(chǎn)品 生物試劑 實驗耗材 藥物研發(fā)等產(chǎn)品。

關(guān)注我們

服務(wù)熱線

400-021-2200

掃一掃,關(guān)注我們

国产A国产片国产| 久久99精品久久久久久hb无码| 国产精品视频一区二区三区无码| 国产伦精品免编号公布| 国产亚洲精品久久久久久| 97久久人人超碰国产精品| 无码 人妻 在线 视频| 亚州日本乱码一区二区三区| 亚洲av无码片一区二区三区| 国产av国片精品无套内谢无码 | 亚洲精品无码久久| 亚洲AV人无码综合在线观看| 被老外添嫩苞添高潮np视频| 四虎AV永久在线精品免费观看 | 精品无人区无码乱码av片国产| 艳乳欲仙欲死在线观看| 亚洲国产三级在线观看| 国产精品国产三级区别第一集| 乱码午夜-极国产极内射| 色综合AV综合无码综合网站| 精品久久久久久无码人妻蜜桃| 色噜噜综合熟女人妻一区| 亚洲AV影院一区二区三区| 亚洲av无码一区二区三区性色| 亚洲JLZZJLZZ少妇| 亚洲国产成人精品无码区在线观看| 久久久精品国产sm调教网站| 国产无遮挡又黄又爽免费视频| 国产乱妇乱子在线播视频播放网站| 亚洲欧美人成无码苍井空| 亚洲精品欧美综合一区二区| 无码AV免费一区二区三区试看| 国产精品无码mv在线观看| 无遮挡国产高潮视频免费观看| 成 人 网 站94免费观看| 国产色婷亚洲99精品av在| YYYY11111少妇影院| 久久99精品久久久久久水蜜桃| 日本妇人成熟a片免费现看| 性一交一乱一乱一视频| 欧美交换配乱吟粗大|